Athira Pharma, Inc.

NASDAQ:ATHA

0.4649 (USD) • At close September 19, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 001.6560000000000000000000
Kosten van de omzet 0.2420.2420.2450.2440.2970.2870.2880.2930.2680.1990.1260.1230.1180.11200000000
Brutowinst -0.242-0.2421.411-0.244-0.297-0.287-0.288-0.293-0.268-0.199-0.126-0.123-0.118-0.11200000000
Brutowinstmarge 000.8520000000000000000000
Onderzoek- en ontwikkelingskosten 21.91220.99423.43527.20221.61521.29315.23616.96514.80314.4612.61810.70712.0247.4455.1875.831.6770.5920.6581.0261.0551.055
Algemene en administratieve kosten 5.8746.4516.9627.8410.0258.4777.6917.1688.7668.9276.167.1194.6133.3363.8921.5670.5750.6750.4590.5090.3440.344
Verkoop- en marketingkosten 0000000000000000000000
Verkoop-, algemene en administratieve kosten 5.8746.4516.9627.8410.0258.4777.6917.1688.7668.9276.167.1194.6133.3363.8921.5670.5750.6750.4590.5090.3440.344
Overige kosten 1.1691.351.7292.0722.043-0.157-1.227-2.9590.493-2.2346.499-2.079-2.589-1.831-0.817-1.059-0.1080.097-0.049-0.02100
Bedrijfskosten 27.78627.44530.39735.04231.6429.61321.721.17424.82821.15316.44215.74714.0488.957.787.3972.2521.2450.8351.3461.2761.276
Bedrijfsresultaat -28.028-27.687-30.642-35.042-31.64-29.77-32.927-24.133-23.569-23.387-18.778-17.826-16.637-10.781-9.079-7.397-2.252-1.267-1.117-1.535-1.399-1.399
Bedrijfsresultaat ratio 00-18.5040000000000000000000
Totaal overige inkomsten en kosten netto 1.1691.353.3572.0722.0431.952.7923.9440.4932.4072.4392.1522.6631.915-0.243-1.0590.404-0.348-0.036-0.0980.070.07
Inkomen voor belasting -26.859-26.337-27.285-32.97-29.597-27.82-30.135-20.189-24.335-20.98-16.339-15.674-13.974-8.866-7.702-8.456-1.992-1.805-0.974-1.53-1.329-1.329
Inkomen voor belasting ratio 00-16.4760000000000000000000
Belastingkosten 00.1992.194-0.2440.122-1.95-4.433-3.944-0.047-2.4071.9782.1532.5891.9150.421-0.0010.1440.19-0.179-0.1030.070.07
Nettowinst -26.859-26.337-27.285-32.97-29.597-25.87-25.702-16.245-24.335-18.573-16.339-15.674-13.974-8.866-7.702-8.456-1.992-1.805-0.974-1.53-1.329-1.329
Nettowinstmarge 00-16.4760000000000000000000
WPA (Winst Per Aandeel) -0.7-0.69-0.72-0.87-0.78-0.68-0.68-0.43-0.65-0.49-0.44-0.42-0.38-0.25-0.22-1.12-0.069-0.21-0.11-0.18-0.37-0.37
Verwaterde WPA -0.7-0.69-0.72-0.87-0.78-0.68-0.68-0.43-0.65-0.49-0.44-0.42-0.38-0.25-0.22-1.12-0.069-0.21-0.11-0.18-0.37-0.37
EBITDA -27.786-27.445-30.397-35.042-31.396-29.613-21.461-20.943-24.607-20.824-16.674-15.55-13.93-8.754-6.787-7.397-2.356-1.142-0.877-1.3550.070.07
EBITDA ratio 00-18.3560000000000000000000